Novartis Fights Bid For Sanctions Over Remand Issue

Law360, New York (August 8, 2007, 12:00 AM EDT) -- Novartis has lashed out at a bid by two plaintiffs in the Aredia and Zometa litigation over their bid to sanction the pharmaceutical company for refusing to remand their cases to state court, arguing that recent case law warrants that the court deny the plaintiffs’ remand request.

The drug giant said in court documents filed Monday that recent New Jersey case law permitting a jury to determine whether a pharmaceutical manufacturer committed fraud to the U.S. Food and Drug Administration and thus may be liable for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.